Italy-based law firm Portolano Cavallo has hired two members to its life sciences practice.
UK charitable foundation the Wellcome Trust has revealed plans to provide up to £500 million ($624 million) to help researchers and organisations turn discoveries and inventions into treatments, products and cures for disease.
The European Commission has given Abbott Laboratories the green light to acquire diagnostic test maker Alere.
Global intellectual property strategy will be the chief area of focus for IP counsel in the life sciences arena in 2017.
The Federal Trade Commission and the Department of Justice have issued an update to the Antitrust Guidelines for Licensing of Intellectual Property, modernising the 1995 guidelines.
The US Court of Appeals for the Federal Circuit has reversed and remanded a patent dispute centring on a cannulated scalpel, a method of knee surgery.
The US Court of Appeals for the Federal Circuit has affirmed a Patent Trial and Appeal Board decision that said patent claims owned by Ethicon, a subsidiary of Johnson & Johnson (J&J), are invalid.
Healthcare company Abbott Laboratories has agreed to divest two medical device businesses in a bid to settle competition charges brought by the US Federal Trade Commission.
Ethicon Endo Surgery, a subsidiary of Johnson & Johnson, has filed a complaint for declaratory judgment of non-infringement against Covidien, which is owned by Medtronic.
Sloan Kettering Institute for Cancer Research, based in New York, and Juno Therapeutics have filed a complaint for declaratory judgment of patent infringement against Kite Pharma.